Abstract
Background
The incidence of myocardial infarction (MI) is elevated in patients receiving renal replacement therapy (RRT). We hypothesized that an invasive strategy of assessment of coronary artery disease (CAD) will identify patients more prone to developing MI.
Methods
This was a single-center observational cohort study that included 1678 patients receiving RRT (hemodialysis and renal transplantation) assessed for CAD prospectively and analyzed retrospectively. Endpoints were the incidence of MI and death.
Results
The median follow-up was 43 months, and 180 patients experienced an MI with a mortality rate of 74%. Multivariate analysis showed that diabetes (HR 1.633; 95% CI 1.165–2.289), prior MI (HR 1.724; 95% CI 1.153–2.579), and CAD (HR 2.073; 95% CI 1.400–3.071) were predictors of MI. Altered myocardial scan did not correlate with MI. At the discretion of the attending physicians, 20/180 patients (11%) underwent coronary intervention that was associated with a higher cumulative survival (Log-rank 0.007).
Conclusion
Patients with CAD suffered an MI more frequently, independently of symptoms and risk factors for MI, including noninvasive testing. Because of the elevated rate of the lethality of MI, invasive coronary studies may be indicated in select patients on RRT. Once an MI occurs, our data suggest that an invasive therapeutic approach is warranted.
Similar content being viewed by others
Availability of data and material
Not applicable.
Code availability
Not applicable.
References
Iseki K, Fukiyama K, for the Okinawa Dialysis Study Group (2000) Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. Am J Kidney Dis 36:820–822
Sánchez-Perales C, Vázquez-Ruiz de Castroviejo E, Segura-Torres P et al (2012) Incidence of acute myocardial infarction in the evolution of dialysis patients. Nefrologia 32:597–604
Shroff GR, Li S, Herzog CA (2015) Trends in mortality following acute myocardial infarction among dialysis patients in the United States over 15 years. J Am Heart Assoc 4:e002460. https://doi.org/10.1161/JAHA.115.002460
Ambrose JA, Tannebaum MA, Alexopoulos D et al (1988) Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12:56–62
Gibson RS, Watson DD, Craddock GB et al (1983) Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 68:321–336
Sarnak MJ, Amann K, Bangalore S et al (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74:1823–1838
Kasiske BL, Maclean JR, Snyder JJ (2006) Acute myocardial Infarction and kidney transplantation. J Am Soc Nephrol 17:900–907. https://doi.org/10.1681/ASN.200509098
Didier R, Yao H, Legendre M et al (2020) Myocardial infarction after kidney transplantation: a risk and specific profile analysis from a Nationwide French Medical Information Database. J Clin Med 9:3356. https://doi.org/10.3390/jcm9103356
Szummer K, Lundman P, Jacobson SH et al (2009) Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 120:851–858
Nauta SJ, van Domburg RT, Nuis R-J et al (2013) Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. Kidney Int 84:353–358
Huang HD, Alam M, Hamzeh I et al (2013) Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol 168:3741–3746
Kasiske BL, Cangro CB, Hariharan S et al (2001) The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1(Suppl 2):3–95
De Lima JJG, Gowdak LHW, de Paula FJ, Ramires JAF, Bortolotto LA (2012) The role of myocardial scintigraphy in the assessment of cardiovascular risk in patients with end-stage chronic kidney disease on the waiting list for renal transplantation. Nephrol Dial Transplant 27:2979–2984
De Lima JG, Gowdak LHW, de Paula FJ, Muela HCS, David-Neto E, Bortolotto LA (2016) Coronary artery disease assessment and intervention in renal transplant patients: analysis from the KiHeart cohort. Transplantation 100:1580–1587
Trespalacios FC, Taylor AJ, Agodoa LY, Abbot KC (2002) Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 62:1799–1805
Andrade JM, Gowdak LHW, Giorgi MCP et al (2009) Cardiac MRI for detection of unrecognized myocardial infarction in patients with end-stage renal disease: comparison with ECG and scintigraphy. AJR Am J Roentgenol 193:W25–W32. https://doi.org/10.2214/AJR.08.1389
Wang CCL, Hess CN, Hiatt HR, Goldfine AB (2016) Clinical update: cardiovascular disease in diabetes mellitus atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus—mechanisms, management, and clinical considerations. Circulation 133:2459–2502
Meier-Kriesche H, Schold JD, Srinivas TR, Reed A, Kaplan B (2004) Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 4:1662–1688
Lentine KL, Costa SP, Weir MR et al (2012) Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 60:434–480
Abramowicz D, Cochat P, Claas FH et al (2015) European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant 30:1790–1797
Bangalore S, Maron DJ, O’Brien SM et al (2020) Management of coronary disease in patients with advanced kidney disease. N Engl J Med 382:1608–1618
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
JJGDL: participated in research design, participated in the writing of the paper, participated in the performance of the research, participated in data analysis. LHWG: participated in research design, participated in the performance of the research, participated in data analysis. JORJ: participated in research design, participated in data analysis. ED-N: participated in data analysis. LAB: participated in research design, participated in data analysis.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to declare.
Ethics approval
All procedures performed involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number 3428/10/17) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
We consent to have this manuscript published.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Lima, J.J.G., Gowdak, L.H.W., Reusing, J.O. et al. Invasive coronary artery disease assessment and myocardial infarction in patients on renal replacement therapy. Int Urol Nephrol 54, 2083–2092 (2022). https://doi.org/10.1007/s11255-022-03115-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03115-6